Clinical Trials Browser

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

26 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT05173142 2022-03-08

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

Phase 1/2 Unknown

141 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05103917 2021-11-02

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Phase 1/2 Unknown

24 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors

CAN1012 Combined With PD-1 in Patients With Solid Tumors

9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC